Oral and dental management for people with lymphoma. (2nd February 2019)

• Record Type: Journal Article
• Authors: Abed, Hassan; Nizarali, Najla; Burke, Mary
• Is Part Of: Dental update. Volume 46:Number 2(2019)
• Page Start: 133
• Page End: 150
• Publication Date: 2019-02-02
• Subjects: Dentistry -- Periodicals; 617.6
• DOI: 10.12968/denu.2019.46.2.133
• Languages: English
• ISSNs: 0305-5000

Abstract

Abstract : Abstract: A lymphoma is a solid neoplasm that arises in lymphoid tissues and spreads to distant lymphoid glands and organs. Functional lymphocytes circulate the body in the lymphatic system as a part of the immune system. In lymphoma, proliferated abnormal lymphocytes collect in the lymphatic glands and organs with variant signs and symptoms based on the affected site. There are two main types of lymphoma: Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL), with different subtypes. The major aetiology is still unknown. Varying treatment modalities are available including monoclonal antibodies, chemotherapy, radiotherapy, corticosteroids and haematopoietic stem cell transplant (HSCT). These have acute and longer-term side-effects that affect clinical decision-making for dental treatment. Therefore, people with lymphoma benefit from a pre-treatment dental assessment and should have regular follow-up in primary care. CPD/Clinical Relevance: This paper aims to provide dental care providers in the primary care setting, community dental service or hospital dental setting with knowledge to manage patients diagnosed with lymphoma.